We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.57B
AUM Growth
+$203M
Cap. Flow
+$147M
Cap. Flow %
9.31%
Top 10 Hldgs %
84.02%
Holding
361
New
29
Increased
183
Reduced
103
Closed
20

Top Buys

Rank Stock Value
1
VUSE icon
Vident US Equity Strategy ETF
VUSE
+$111M
2
VIDI icon
Vident International Equity Strategy
VIDI
+$21.3M
3
IAU icon
iShares Gold Trust
IAU
+$10M
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$2.59M
5
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$2.08M

Top Sells

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$3.69M
2
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$3.33M
3
TIP icon
iShares TIPS Bond ETF
TIP
+$2.43M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$922K
5
AZN icon
AstraZeneca
AZN
+$899K

Sector Composition

Rank Sector Weight
1 Healthcare 2.52%
2 Financials 2.31%
3 Energy 2.1%
4 Industrials 1.95%
5 Consumer Staples 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEE icon
101
NextEra Energy
NEE
$181B
$798K 0.05%
31,148
+1,460
+5% +$35.5K
NSC icon
102
Norfolk Southern
NSC
$75.4B
$793K 0.05%
7,694
-41
-0.5% -$4.02K
KMB icon
103
Kimberly-Clark
KMB
$36.3B
$792K 0.05%
7,432
+368
+5% +$39.1K
DD icon
104
DuPont de Nemours
DD
$18.5B
$789K 0.05%
6,052
+261
+5% +$33.3K
SI
105
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$789K 0.05%
5,967
-345
-5% -$46.1K
UN
106
DELISTED
Unilever NV New York Registry Shares
UN
$788K 0.05%
18,017
+922
+5% +$39.6K
SNY icon
107
Sanofi
SNY
$103B
$786K 0.05%
14,783
-1,146
-7% -$60.8K
LOW icon
108
Lowe's Companies
LOW
$117B
$779K 0.05%
16,226
-3,086
-16% -$144K
TEVA icon
109
Teva Pharmaceuticals
TEVA
$40.8B
$766K 0.05%
14,614
+1,978
+16% +$101K
ABT icon
110
Abbott
ABT
$183B
$763K 0.05%
18,670
+75
+0.4% +$2.94K
LMT icon
111
Lockheed Martin
LMT
$134B
$761K 0.05%
4,730
-19
-0.4% -$3.09K
BKNG icon
112
Booking.com
BKNG
$149B
$760K 0.05%
15,800
+1,300
+9% +$62.4K
BRK.A icon
113
Berkshire Hathaway Class A
BRK.A
$1.1T
$760K 0.05%
4
– –
BIDU icon
114
Baidu
BIDU
$37.7B
$750K 0.05%
4,017
+870
+28% +$142K
GSK icon
115
GSK
GSK
$104B
$750K 0.05%
11,218
+1,602
+17% +$108K
SBUX icon
116
Starbucks
SBUX
$120B
$742K 0.05%
19,198
+2,018
+12% +$73.3K
BMY icon
117
Bristol-Myers Squibb
BMY
$133B
$734K 0.05%
15,130
+1,657
+12% +$81.7K
META icon
118
Meta Platforms (Facebook)
META
$1.42T
$734K 0.05%
10,913
+2,261
+26% +$139K
DBP icon
119
Invesco DB Precious Metals Fund
DBP
$237M
$733K 0.05%
17,004
-15,259
-47% -$633K
AXP icon
120
American Express
AXP
$227B
$728K 0.05%
7,669
+358
+5% +$32.3K
CELG
121
DELISTED
Celgene Corp
CELG
$727K 0.05%
8,466
+620
+8% +$47.1K
BHP icon
122
BHP
BHP
$215B
$714K 0.05%
12,342
+1,411
+13% +$82.9K
CL icon
123
Colgate-Palmolive
CL
$73.1B
$709K 0.05%
10,402
+1,872
+22% +$125K
GLD icon
124
SPDR Gold Trust
GLD
$131B
$708K 0.05%
5,532
-360
-6% -$44.7K
ARMH
125
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$706K 0.04%
15,604
+2,967
+23% +$138K
3 4
5
6 7

Similar funds

DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return
1GA
1st Global Advisors Dallas, Texas $869M AUM 16.28% 1-Year Est. Return

Ronald Blue & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Ronald Blue & Co held 361 positions worth $1.57B, up 15% from $1.37B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Ronald Blue & Co deployed $147M of net new capital in Q2 2014, opening 29 new positions and adding to 183 existing holdings. Its largest new stake was Alphabet (Google) Class C: 61,889 shares worth $1.79M.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, down from 2.7% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was iShares MSCI ACWI ETF, an estimated $3.69M trimmed.

  • Ronald Blue & Co's largest Q2 2014 buy was Alphabet (Google) Class C: 61,889 shares worth $1.79M.
  • Ronald Blue & Co added most to Vident US Equity Strategy ETF in Q2 2014, an estimated $111M increase.
  • Ronald Blue & Co's biggest Q2 2014 reduction was iShares MSCI ACWI ETF, cutting an estimated $3.69M.
  • Ronald Blue & Co fully exited Vale in Q2 2014, selling an estimated $741K.
  • Ronald Blue & Co's ten largest holdings make up 84% of its $1.57B portfolio in Q2 2014.
  • Ronald Blue & Co opened 29 new positions and closed 20 in Q2 2014.
  • Ronald Blue & Co's portfolio value rose 15% quarter-over-quarter to $1.57B.

Based on Ronald Blue & Co's 13F filing for Q2 2014, filed 6 Aug 2014.